Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: Conformational and biological implications

Journal of Medicinal Chemistry

Volumn 39, Issue 14, 1996, Pages 2738-2744

  Zhang, Wei Jun ^a   Nikiforovich, Gregory V ^b   Pérodin, Jacqueline ^a   Richard, Darren E ^a   Escher, Emanuel ^a   Marshall, Garland R ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CYCLIZATION; DATA ANALYSIS; DISULFIDE BOND; DRUG CONFORMATION; NUCLEAR MAGNETIC RESONANCE; RECEPTOR AFFINITY;

AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; FEMALE; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE CONTRACTION; PROTEIN CONFORMATION; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; VASOCONSTRICTOR AGENTS;

EID: 0029995902     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9507744     Document Type: Article

References (32)

1. Duncia, J. V.; Chiu, A. T.; Carini, D. J.; Gregory, G. B.; Johnson, A. L.; Price, W. A.; Wells, G. J.; Wong, P. C.; Calabrese, J. C.; Timmermans, P. B. M. W. M. The Discovery of Potent Nonpeptide Angiotensin II Receptor Antagonists: A New Class of Potent Antihypertensives. J. Med. Chem. 1990, 33, 1312-1329.
2. Nikiforovich, G. V. Computational molecular modeling in peptide design. Int. J. Pept. Protein Res. 1994, 44, 513-531.
3. Chipens, G.; Nikiforovich, G.; Mutulis, F.; Veretennikova, N.; Vosekalna, I.; Sosnov, A.; Polevaya, L.; Ancans, J.; Mishlyakova, N.; Liepinsh, E.; Sekacis, I.; Breslav, M. Cyclic analogs of linear peptides. In Peptides. Structure and Biological Function. Proceedings of the Sixth American Peptide Symposium; Gross, E., Meienhofer, J., Eds.; Pierce Chemical Co.: Rockford, IL, 1979; pp 567-570.
4. De Coen, J.-L.; Ralston, E.; Durieus, J. P.; Loffet, A. Cyclic angiotensin. In Peptides: Chemistry, Structure and Biology. Proceedings of the 4th American Peptide Symposium; Walter, R., Meienhofer, J., Eds.; Pierce Chemical Co.: Ann Arbor, MI, 1975; pp 553-558.
5. Matsoukas, J. M.; Hondrelis, J.; Agelis, G.; Barlos, K.; Gatos, D.; Ganter, R.; Moore, D.; Moore, G. J. Novel Synthesis of Cyclic Amide-Linked Analogues of Angiotensins II and III. J. Med. Chem. 1994, 37, 2958-2969.
6. Miranda, A.; Juliano, L. Conformationally restricted analogs af angiotensin II: Titration and biological activity. Braz. J. Med. Biol. Res. 1988, 21, 903-914.
7. Spear, K. L.; Brown, M. S.; Reinhard, E. J.; McMahon, E. G.; Olins, G. M.; Palomo, M. A.; Patton, D. R. Conformational Restriction of Angiotensin II: Cyclic Analogues Having High Potency. J. Med. Chem. 1990, 33, 1935-1940.
8. 8]-Angiotensin II. In Peptides: Chemistry, Structure and Biology. Proceedings of the Eleventh American Peptide Symposium; Rivier, J., Marshall, G. R., Eds.; ESCOM Publishers: Leiden, 1989; pp 305-306.
9. Turk, J.; Needleman, P.; Marshall, G. R. Analogues of Angiotensin II with Restricted Conformational Freedom, Including a New Antagonist. Mol. Pharmacol. 1976, 12, 217-224.
10. Chipens, G. I.; Ancan, Y. E.; Nikiforovich, G. V.; Balodis, Y. Y.; Makarova, N. A. Synthesis and Conformational Analysis of New Angiotensin Analogues Containing Aza-α-Homoamino Acids. In Peptides 1978; Siemion, I. Z., Kupryszewski, G., Eds.; Wroclaw University Press: Wroclaw, 1979; pp 415-419.
11. Plucinska, K.; Kataoka, T.; Yodo, M.; Cody, W. L.; He, J. X.; Humblet, C.; Lu, G. H.; Lunney, E.; Major, T. C.; Panek, R. L.; Schelkun, P.; Skeean, R.; Marshall, G. R. Multiple Binding Modes for The Receptor-Bound Conformations of Cyclic All Agonists. J. Med. Chem. 1993, 36, 1902-1913.
12. Nikiforovich, G. V.; Kao, J. L.-F.; Plucinska, K.; Zhang, W. J.; Marshall, G. R. Conformational Analysis of Two Cyclic Analogs of Angiotensin: Implications for the Biologically Active Conformation. Biochemistry 1994, 33, 3591-3598.
13. Regoli D.; Park, W. K.; Rioux, F. Pharmacology of Angiotensin. Pharm. Rev. 1974, 26, 69-123.
14. Nikiforovich, G. V.; Marshall, G. R. Three-dimensional recognition requirements for angiotensin agonists: A novel solution for an old problem. Biochem. Biophys. Res. Commun. 1993, 195, 222-228.
15. Tam, J. P.; Wu, C.-R.; Liu, W.; Zhong, J. W. Disulfide Bond Formation in Peptides by Dimethyl Sulfoxide. Scope and Application. J. Am. Chem. Soc. 1991, 113, 6657.
16. Samanen, J.; Cash, T.; Narindray, D.; Brandeis, E.; Adams, W., Jr; Weideman, H.; Yellin, T. An Investigation of Angiotensin II Agonist and Antagonist Analogues with 5,5-Dimethylthiazolidine-4-carboxylic Acid and Other Constrained Amino Acids. J. Med. Chem. 1991, 34, 3036-3043.
17. Marshall, G. R.; Vine, W.; Needleman, P. A specific competitive inhibitor of angiotensin II. Proc. Natl. Ac. Sci. U.S.A. 1970, 67, 1624-1630.
18. Samanen, J.; Cash, T.; Narindray, D.; Brandeis, E.; Yellin, T.; Regoli, D. The Role of Position 4 in Angiotensin II Antagonism: A Structure-Activity Study. J. Med. Chem. 1989, 32, 1366-1370.
19. Eswarakrishnan, V.; Lamar, F. Sulfenic acids and related compounds. 13. Unsymmetrical disulfides based on methyl-4-mercapto-butanesulfinate and 4(S)- or 4(R)-mercaptoprolines. J. Org. Chem. 1981, 46, 4182.
20. Fraker, P. J.; Speck, J. C. Protein and cell iodination with a sparingly soluble chloroamine, 1,3,4,6-tetrachloro-3α,6α-diphenylglycoloryl. Biochem. Biophys. Res. Commun. 1978, 80, 849-857.
21. Dunfield, L. G.; Burgess, A. W.; Scheraga, H. A. Energy Parameters in Polypeptides. 8. Empirical Potential Energy Algorithm for the Conformational Analysis of Large Molecules. J. Phys. Chem. 1978, 82, 2609-2616.
22. Nemethy, G.; Pottle, M. S.; Scheraga, H. A. Energy Parameters in Polypeptides. 9. Updating of Geometrical Parameters, Non-bonded Interactions, and Hydrogen Bond Interactions for the Naturally Occuring Amino Acids. J. Phys. Chem. 1983, 87, 1883-1887.
23. Zimmerman, S. S.; Scheraga, H. A. Influence of Local Interactions on Protein Structure. I. Conformational Energy Studies of N-Acetyl-N′-Methylamides of Pro-X and X-Pro Dipeptides. Biopolymers 1977, 16, 811-843.
24. Nikiforovich, G. V.; Hruby, V. J.; Prakash, O.; Gehrig, C. A. Topographical Requirements for Delta-Selective Opioid Peptides. Biopolymers 1991, 31, 941-955.
25. Nyburg, S. C. Some uses of a best molecular fit routine. Acta Crystallogr. 1974, B30 (part I), 251-253.
26. Cheng, Y.; Prussof, W. M. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 1978, 22, 3099-3108.
27. Samanen, J. M.; Peishoff, C. E.; Keenan, R. M.; Weinstock, J. Refinement of a molecular model of angiotensin II employed in the discovery of potent nonpeptide antagonists. Bioorg. Med. Chem. Lett. 1992, 3, 909-914.
28. Joseph, M. P.; Maigret, B.; Scheraga, H. A. Proposals for the angiotensin II receptor-bound conformation by comparative computer modeling of All and cyclic analogs. Int. J. Pept. Protein Res. 1995, 46, 514-526.
29. Bosse, R.; Gerold, M.; Fischli, W.; Holck, M.; Escher, E. An Angiotensin with Prolonged Action and Blood Pressure-Lowering Properties J. Cardiovasc. Pharmacol. 1990, 16 (suppl. 4), S50-S55.
30. 1 receptor. J. Biol. Chem. 1994, 269, 30953-30959.
31. 4 Analogs: Synthesis and Implications for the CCK-B Receptor-Bound Conformation. J. Med. Chem. 1995, 38, 137-149.
32. Webb, T. R.; Eigenbrot, C. Conformationally Restricted Arginine Analogues. J. Org. Chem. 1991, 56, 3009-3016.